GlaxoSmithKline PLC ADR (GSK) — Free Cash Flow Generation Index
GlaxoSmithKline PLC ADR (GSK) has a Free Cash Flow Generation Index of 0.61x as of March 2026. Free cash flow of $698.00 Million represents 1% of operating cash flow ($1.14 Billion). Read GlaxoSmithKline PLC ADR (GSK) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline PLC ADR Free Cash Flow Generation Index (1990–2025)
Historical FCF Generation Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. Explore GlaxoSmithKline PLC ADR (GSK) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year Free Cash Flow Generation Index for GlaxoSmithKline PLC ADR. For the full company profile including market capitalisation, see GSK market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | $5.82 Billion | $7.14 Billion | $1.32 Billion | ▲ +49.6% |
| 2024 | 0.55x | $3.57 Billion | $6.55 Billion | $2.98 Billion | ▼ -31.3% |
| 2023 | 0.79x | $6.26 Billion | $7.89 Billion | $1.63 Billion | ▲ +14.1% |
| 2022 | 0.69x | $5.14 Billion | $7.40 Billion | $2.26 Billion | ▲ +10.1% |
| 2021 | 0.63x | $5.02 Billion | $7.95 Billion | $2.93 Billion | ▼ -14.1% |
| 2020 | 0.73x | $6.20 Billion | $8.44 Billion | $2.24 Billion | ▲ +0.6% |
| 2019 | 0.73x | $5.86 Billion | $8.02 Billion | $2.16 Billion | ▼ -7.2% |
| 2018 | 0.79x | $6.62 Billion | $8.42 Billion | $1.80 Billion | ▲ +15.4% |
| 2017 | 0.68x | $4.72 Billion | $6.92 Billion | $2.20 Billion | ▲ +6.9% |
| 2016 | 0.64x | $4.14 Billion | $6.50 Billion | $2.35 Billion | ▲ +145.4% |
| 2015 | 0.26x | $668.00 Million | $2.57 Billion | $1.90 Billion | ▼ -60.7% |
| 2014 | 0.66x | $3.42 Billion | $5.18 Billion | $1.75 Billion | ▼ -13.4% |
| 2013 | 0.76x | $5.52 Billion | $7.22 Billion | $1.70 Billion | ▲ +17.1% |
| 2012 | 0.65x | $2.85 Billion | $4.38 Billion | $1.52 Billion | ▼ -17.1% |
| 2011 | 0.79x | $4.92 Billion | $6.25 Billion | $1.33 Billion | ▲ +3.7% |
| 2010 | 0.76x | $5.16 Billion | $6.80 Billion | $1.64 Billion | ▼ -0.2% |
| 2009 | 0.76x | $5.97 Billion | $7.84 Billion | $1.87 Billion | ▲ +6.2% |
| 2008 | 0.72x | $5.24 Billion | $7.31 Billion | $2.07 Billion | ▲ +13.8% |
| 2007 | 0.63x | $3.65 Billion | $5.79 Billion | $2.14 Billion | ▲ +5.3% |
| 2006 | 0.60x | $2.37 Billion | $3.96 Billion | $1.59 Billion | ▼ -24.1% |
| 2005 | 0.79x | $4.41 Billion | $5.59 Billion | $1.18 Billion | ▼ -16.7% |
| 2004 | 0.95x | $4.51 Billion | $4.77 Billion | $255.00 Million | ▲ +21.2% |
| 2003 | 0.78x | $3.79 Billion | $4.85 Billion | $1.06 Billion | ▲ +30.4% |
| 2002 | 0.60x | $1.83 Billion | $3.06 Billion | $1.23 Billion | ▼ -20.9% |
| 2001 | 0.76x | $3.49 Billion | $4.61 Billion | $1.12 Billion | ▲ +87.3% |
| 2000 | 0.40x | $749.00 Million | $1.85 Billion | $1.10 Billion | ▲ +337.1% |
| 1999 | -0.17x | $-87.00 Million | $510.00 Million | $597.00 Million | ▼ -7.6% |
| 1998 | -0.16x | $-65.00 Million | $410.00 Million | $475.00 Million | ▼ -148.8% |
| 1997 | 0.33x | $200.00 Million | $615.00 Million | $415.00 Million | ▼ -38.4% |
| 1996 | 0.53x | $448.00 Million | $849.00 Million | $401.00 Million | ▲ +16.3% |
| 1995 | 0.45x | $568.00 Million | $1.25 Billion | $684.00 Million | ▼ -43.4% |
| 1994 | 0.80x | $1.96 Billion | $2.45 Billion | $485.59 Million | ▲ +76.6% |
| 1993 | 0.45x | $478.00 Million | $1.05 Billion | $575.00 Million | ▲ +31.9% |
| 1992 | 0.34x | $319.00 Million | $927.00 Million | $608.00 Million | ▲ +258.9% |
| 1991 | 0.10x | $63.00 Million | $657.00 Million | $594.00 Million | ▲ +555.3% |
| 1990 | 0.01x | $9.00 Million | $615.00 Million | $606.00 Million | — |